Chemed Corporation (CHE)
NYSE: CHE · Real-Time Price · USD
459.63
-4.37 (-0.94%)
At close: Sep 3, 2025, 4:00 PM
459.63
0.00 (0.00%)
Pre-market: Sep 4, 2025, 8:00 AM EDT
Chemed Revenue
Chemed had revenue of $618.80M in the quarter ending June 30, 2025, with 3.85% growth. This brings the company's revenue in the last twelve months to $2.51B, up 7.55% year-over-year. In the year 2024, Chemed had annual revenue of $2.43B with 7.37% growth.
Revenue (ttm)
$2.51B
Revenue Growth
+7.55%
P/S Ratio
2.70
Revenue / Employee
$160,046
Employees
15,695
Market Cap
6.67B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.43B | 166.87M | 7.37% |
Dec 31, 2023 | 2.26B | 129.45M | 6.06% |
Dec 31, 2022 | 2.13B | -4.30M | -0.20% |
Dec 31, 2021 | 2.14B | 59.68M | 2.87% |
Dec 31, 2020 | 2.08B | 141.03M | 7.27% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
CHE News
- 3 days ago - McDonald's And Microsoft Among 12 Companies To Announce Annual Increases In September - Seeking Alpha
- 19 days ago - Chemtrade Logistics Income Fund (CGIFF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Chemed Corporation Board of Directors Authorizes an Additional $300 Million for Stock Repurchase and Declares Quarterly Dividend of 60 Cents - Business Wire
- 5 weeks ago - VITAS® Healthcare Announces CEO Transition and Appointment of New Chief Executive Officer - GlobeNewsWire
- 5 weeks ago - Chemed Corporation (CHE) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Chemed Reports Second-Quarter 2025 Results and Announces Executive Management Departure - Business Wire
- 6 weeks ago - Chemed Corporation: Short-Term Headwinds But Long-Term Growth Potential - Seeking Alpha
- 2 months ago - Chemed To Report Second-Quarter 2025 Earnings July 29, 2025 - Business Wire